Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)
Completed · Not applicable
Conditions studied: Stenosis, Restenosis
In brief
The objective of this study is to assess the safety and effectiveness of the COVERA™ Vascular Covered Stent for the treatment of stenotic lesions in the upper extremity venous outflow of the Arteriovenous (AV) access circuit.
Key facts
- Study ID
- NCT02790606
- Run by
- C. R. Bard
- People needed
- 110
- Starts
- 2016-07-01
- Expected to finish
- 2019-03-16
- Last updated by the study team
- 2020-04-14
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Arizona Kidney Disease and Hypertension Center — Phoenix, Arizona, United States
- Southwest Vascular Center — Tempe, Arizona, United States
- Arizona Kidney Disease and Hypertension Center Medical Research Services, LLC — Tucson, Arizona, United States
- St. Joseph Hospital — Orange, California, United States
- Capital Nephrology Access Center — Sacramento, California, United States
- Jacksonville Center for Clinical Research — Jacksonville, Florida, United States
- Ocala Kidney Group — Ocala, Florida, United States
- Chicago Access Care — Chicago, Illinois, United States
- Renal and Transplant Associates of New England, P.C. — West Springfield, Massachusetts, United States
- The Cardiovascular Care Group — Westfield, New Jersey, United States
- Surgical Specialists of Charlotte — Charlotte, North Carolina, United States
- NC Heart and Vascular Research — Raleigh, North Carolina, United States
- NC Nephrology — Raleigh, North Carolina, United States
- Providence Access Care — Providence, Rhode Island, United States
- Tarrant Vascular Clinic — Fort Worth, Texas, United States
- Clinical Advancement Center, PLLC — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.